tiprankstipranks
Advertisement

BUSA - ETF AI Analysis

Compare

Top Page

BUSA

Brandes U.S. Value ETF (BUSA)

Rating:71Outperform
Price Target:
BUSA, the Brandes U.S. Value ETF, has a solid overall rating, suggesting it holds a generally strong mix of value-oriented U.S. stocks. High-quality holdings like Merck and FedEx support the fund’s rating through robust financial performance, positive earnings outlooks, and strategic growth initiatives, while other names such as Pfizer and Chevron add income potential but face near-term challenges like slowing revenue growth, legal or cash flow issues, and some bearish or overbought technical signals. The main risk factor is that several key holdings share pressures around revenue growth, cash flow, or technical weakness, which could weigh on the fund if economic conditions worsen.
Positive Factors
Solid Recent Performance
The ETF has shown strong gains so far this year and over the past month, indicating positive recent momentum.
Supportive Top Holdings
Several of the largest positions, including major financial, health care, industrial, and technology companies, have delivered strong or steady results that help drive the fund’s returns.
Broad Sector Diversification
The fund spreads its investments across many sectors such as health care, financials, technology, and industrials, which helps reduce the impact if any one industry struggles.
Negative Factors
Higher Expense Ratio
The fund’s expense ratio is on the higher side for an ETF, which means more of the returns go toward fees instead of staying with investors.
Concentrated U.S. Exposure
Almost all of the ETF’s holdings are in U.S. companies, offering little geographic diversification if the U.S. market weakens.
Mixed Financial Sector Performance
While some financial holdings have performed well, others have been weak, which can create uneven results for this important part of the portfolio.

BUSA vs. SPDR S&P 500 ETF (SPY)

BUSA Summary

Brandes U.S. Value ETF (BUSA) is a fund that invests in a wide range of U.S. stocks, focusing on companies the managers believe are undervalued. It doesn’t track a set index, but instead follows a value-investing approach across many sectors like health care, financials, and technology. Well-known holdings include Citigroup, Bank of America, Merck, Pfizer, FedEx, and Alphabet (Google). Someone might invest in BUSA to seek long-term growth by buying solid companies at cheaper prices and getting broad diversification in U.S. stocks. A key risk is that these value stocks can stay out of favor for long periods and the share price can go up and down with the market.
How much will it cost me?The Brandes U.S. Value ETF (BUSA) has an expense ratio of 0.6%, meaning you’ll pay $6 per year for every $1,000 invested. This is higher than average because it is actively managed, with experts selecting undervalued stocks rather than following a passive index.
What would affect this ETF?The Brandes U.S. Value ETF could benefit from a recovery in undervalued sectors like Financials and Health Care, especially if economic conditions improve or interest rates stabilize, supporting growth in these industries. However, rising interest rates or regulatory changes in key sectors like Technology and Energy could negatively impact some of its top holdings, such as Bank of America and Chevron. The ETF's focus on U.S. equities means it is sensitive to domestic economic trends and policy shifts.

BUSA Top 10 Holdings

BUSA leans heavily into U.S. financials and health care, with a value tilt that favors solid but underappreciated names. FedEx and Halliburton have been doing the heavy lifting lately, with both stocks rising and giving the fund a nice cyclical boost. Citigroup and PNC are also climbing, helping the financial sleeve pull its weight, while Bank of America’s more mixed performance keeps that story from being all-out bullish. On the defensive side, Merck and Pfizer are steady contributors, and Alphabet adds a touch of Big Tech without dominating the portfolio.
Name
Company Name
Weight %
Market Value
Market Cap
Yearly Gain
Overall Rating
Citigroup3.04%$8.81M$225.82B95.67%
68
Neutral
Bank of America2.49%$7.21M$383.81B37.08%
72
Outperform
Textron2.46%$7.13M$15.81B35.07%
75
Outperform
Merck & Company2.42%$7.00M$278.29B43.37%
80
Outperform
FedEx2.33%$6.75M$94.15B82.88%
79
Outperform
Halliburton2.28%$6.61M$31.86B89.76%
72
Outperform
Cigna2.21%$6.39M$72.95B-18.41%
72
Outperform
Pfizer2.19%$6.35M$155.35B19.70%
74
Outperform
Alphabet Class C2.19%$6.33M$4.01T114.13%
82
Outperform
PNC Financial2.14%$6.20M$91.99B42.98%
71
Outperform

BUSA Technical Analysis

Technical Analysis Sentiment
Positive
Last Price
Price Trends
50DMA
37.93
Positive
100DMA
37.50
Positive
200DMA
35.78
Positive
Market Momentum
MACD
0.39
Negative
RSI
62.14
Neutral
STOCH
70.77
Neutral
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For BUSA, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 37.85, equal to the 50-day MA of 37.93, and equal to the 200-day MA of 35.78, indicating a bullish trend. The MACD of 0.39 indicates Negative momentum. The RSI at 62.14 is Neutral, neither overbought nor oversold. The STOCH value of 70.77 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for BUSA.

BUSA Peer Comparison

Comparison Results
Name
Price
Price Target
AUM
Expense Ratio
Overall Rating
$292.37M0.60%
71
Outperform
$813.49M0.13%
69
Neutral
$595.27M0.40%
75
Outperform
$520.34M0.28%
73
Outperform
$396.12M0.38%
70
Outperform
$223.25M0.50%
70
Neutral
Performance Comparison
Ticker
Company Name
Price
Change
% Change
BUSA
Brandes U.S. Value ETF
38.71
8.25
27.08%
VFVA
Vanguard U.S. Value Factor ETF
LSVD
LSV Disciplined Value ETF
QVAL
Alpha Architect U.S. Quantitative Value ETF
AIVL
WisdomTree U.S. AI Enhanced Value Fund
GVLU
Gotham 1000 Value ETF
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents
Advertisement